Bisphosphocins have the potential to save billions of dollars in hospital stays and lengthy treatments versus conventional standard of care antibiotics.VIEW MORE
With over 100 years of combined pharmaceutical industry experience, our leadership team has the expertise to efficiently bring bisphosphocins to market.
A rapid and safe topical bactericide and fungicide has the potential to save millions of lives.
Bisphosphocins rapidly kill bacteria and fungi by depolarizing microbial cell membranes, leading to cell death within minutes.
Chronic Diabetic Foot Ulcers (cDFU)
Cystic Fibrosis (CF)
Published on Feb 23, 2018
SNNLive spoke with Steve Parkinson, President and CEO of Lakewood-Amedex, Inc., a private company, at the BIO CEO & Investor Conference 2018 in New York City, NY.
Steve Parkinson, President and CEO of Lakewood-Amedex (a privately-held, clinical stage pharmaceutical company), discusses their development of a broad portfolio of first-in-class antimicrobial and antifungal therapeutics called bisphosphocins™.
Lakewood-Amedex, Inc. Advances Bisphosphocin Nu-8 to IND-Enabling Studies to Treat Complicated Urinary Tract Infection
Lakewood-Amedex, Inc. to Present at 2018 BIO CEO & Investor Conference